BioInvest 2005, the Biotechnology and Discovery Informatics Investment Meeting Selects 9 Companies to Present in London

Share Article

Register now to attend BioInvest 2005, the bioinformatics and biotechnology investment conference to be held at the DTI conference centre in London. The conference will be a showcase for emerging international biotechnology and bioinformatics companies. Investor pitches by companies will be focused on biotechnology companies in the morning, drug discovery and life sciences informatics in the afternoon. Venue: DTI Conference Centre, 1 Victoria Street, London SW1E 0ET - Web site: http://www.bioinvest2005.com

Register now to attend Bioinvest 2005, the bioinformatics and biotechnology investment conference to be held at the DTI conference centre in London. The conference will be a showcase for emerging international biotechnology and bioinformatics companies. Investor pitches by companies will be focused on biotechnology companies in the morning, bioinformatics in the afternoon.

Northbank Communications is the communications partner for the new BioInvest 2005 Conference, an initiative of the UK Bioinformatics Forum and Oxfordshire Bioscience Network and Oxford Science Enterprise Centre, Said Business School. BioInvest 2005 is offering 50% off registration for a second company delegate and free entry for a third company delegate. First delegate rate is just £100. Includes refreshments, lunch and wine reception.

Networking drinks reception from 16.30 – 19.00 at the conference venue.

Attendees will include seed fund managers, angel investors, venture capitalists, private equity managers and biotech/pharmaceutical executives, all looking for investment opportunities within the biotech and bioinformatics industries.

BioInvest 2005 allows investors to meet with leading and emerging biotechnology and informatics companies. Companies presenting include*:

Robert Feldman, CEO, Riotech Pharma

David Laskow Pooley, CEO, Surface Therapeutics

Yasmin Crawford, Director, Opal Healthcare Limited

Dr Dan Daly, Director, Lein Diagnostics

Christian Rohlff, CEO, Oxford Genome Sciences

Andrew Payne, CEO, Intellidos

Mark Tucker, CEO, G-Nostics

Will Saurin, CEO, Genomining

Adlan Hercus, Director, Synamatix

*Company appraisals available on the web site http://www.bioinvest2005.com

Bioinvest 2005 is a joint initiative of the UK Bioinformatics Forum and Oxfordshire Bioscience Network, and Oxford Science Enterprise Centre, Said Business School.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jonathan Rees
Visit website